ciprofloxacin has been researched along with pyrroles in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Brocca-Cofano, E; Del Vecchio, C; Fravolini, A; Gatto, B; Palù, G; Palumbo, M; Parolin, C; Richter, S | 1 |
| Eichhorn, E; Elz, S; Mahboobi, S; Möllmann, U; Popp, A; Sellmer, A | 1 |
| Yang, M | 1 |
| Bai, RJ; Liu, XY | 1 |
| Bouffier, L; Cosnier, S; Gondran, C; Healy, T; Ionescu, RE; Jaffrezic-Renault, N; Marco, MP; Martelet, C; Pinacho, DG; Sánchez-Baeza, FJ | 1 |
| Montgomery, JP; Patterson, PH | 1 |
| Cosnier, S; Giroud, F; Gondran, C; Gorgy, K; Marco, MP; Pinacho, DG; Sánchez-Baeza, FJ | 1 |
| Rane, RA; Telvekar, VN | 1 |
| Housman, ST; Nicolau, DP; Sutherland, C | 1 |
| Esrafilzadeh, D; Moulton, SE; Razal, JM; Stewart, EM; Wallace, GG | 1 |
| Han, GF; Liu, KN; Liu, L; Lu, YX; Sun, L; Wang, QM; Wen, YB; Wu, M; Yin, Z | 1 |
| Grabowski, T; Grześkowiak, E; Karbownik, A; Sobańska, K; Szałek, E; Wolc, A | 1 |
| Bharate, JB; Bharate, SB; Joshi, P; Khan, IA; Kumar, A; Sharma, S; Singh, S; Vishwakarma, RA; Wani, A | 1 |
| Krukiewicz, K; Stokfisz, A; Zak, JK | 1 |
| Gunn, JS; Hoang, KV; Melander, C; Woolard, K; Yang, C | 1 |
| Chen, F; Gong, Z; Hassan, M; He, L; Liu, H; Lv, M; Tan, Q; Zheng, B | 1 |
2 review(s) available for ciprofloxacin and pyrroles
| Article | Year |
|---|---|
Discoveries of Tat-TAR interaction inhibitors for HIV-1.
Topics: Amides; Amino Acid Sequence; Animals; Antiviral Agents; Base Sequence; Ciprofloxacin; Drug Design; Drug Evaluation, Preclinical; Ethidium; Gene Products, tat; HIV Long Terminal Repeat; HIV-1; Humans; Imidazoles; Isoquinolines; Molecular Sequence Data; Nucleic Acid Conformation; Protein Binding; Protein Conformation; Pyrroles; RNA, Viral; tat Gene Products, Human Immunodeficiency Virus | 2005 |
[Transactivation of HIV-1 transcription and inhibitors].
Topics: Anti-HIV Agents; Ciprofloxacin; Gene Products, tat; Genes, tat; HIV-1; Humans; Isoquinolines; Oligopeptides; Organophosphates; Pyrroles; tat Gene Products, Human Immunodeficiency Virus; Transcription, Genetic; Transcriptional Activation; Uridine | 2006 |
14 other study(ies) available for ciprofloxacin and pyrroles
| Article | Year |
|---|---|
Inhibition of human immunodeficiency virus type 1 tat-trans-activation-responsive region interaction by an antiviral quinolone derivative.
Topics: Amino Acid Sequence; Anti-HIV Agents; Ciprofloxacin; DNA, Viral; Gene Products, tat; HIV Long Terminal Repeat; HIV-1; Isoquinolines; Molecular Sequence Data; Mutation; Plasmids; Pyrroles; Quinolones; RNA, Viral; tat Gene Products, Human Immunodeficiency Virus | 2004 |
3-Bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives as new lead compounds for antibacterially active substances.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Gram-Positive Bacteria; Indoles; Microbial Sensitivity Tests; Mycobacterium smegmatis; Pyrroles; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin | 2006 |
Impedimetric immunosensor for the specific label free detection of ciprofloxacin antibiotic.
Topics: Anti-Bacterial Agents; Biosensing Techniques; Ciprofloxacin; Electrochemistry; Immunoassay; Microscopy, Atomic Force; Molecular Structure; Polymers; Pyrroles; Reproducibility of Results | 2007 |
Endothelin receptor B antagonists decrease glioma cell viability independently of their cognate receptor.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Ciprofloxacin; DNA Damage; Endothelin B Receptor Antagonists; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; Humans; Isoquinolines; Melanoma; Oligonucleotide Array Sequence Analysis; Pyrroles; Pyrrolidines; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Small Interfering | 2008 |
Impedimetric immunosensor based on a polypyrrole-antibiotic model film for the label-free picomolar detection of ciprofloxacin.
Topics: Anti-Bacterial Agents; Antibodies, Immobilized; Biosensing Techniques; Ciprofloxacin; Electric Impedance; Electrochemistry; Immunoassay; Limit of Detection; Polymers; Pyrroles | 2009 |
Synthesis and evaluation of novel chloropyrrole molecules designed by molecular hybridization of common pharmacophores as potential antimicrobial agents.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Design; Hydrazines; Microbial Sensitivity Tests; Phenols; Pyrroles; Structure-Activity Relationship | 2010 |
In vitro evaluation of novel compounds against selected resistant Pseudomonas aeruginosa isolates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Cytosine; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pyrroles; Ribosome Subunits, Large, Bacterial; Tobramycin | 2012 |
Multifunctional conducting fibres with electrically controlled release of ciprofloxacin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Delayed-Action Preparations; Electric Conductivity; Escherichia coli; Escherichia coli Infections; Humans; Polymers; Polystyrenes; Pyrroles; Streptococcal Infections; Streptococcus pyogenes; Thiophenes | 2013 |
Optimization of on-line solid phase extraction and HPLC conditions using response surface methodology for determination of WM-5 in mouse plasma and its application to pharmacokinetic study.
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Stability; Isoquinolines; Limit of Detection; Linear Models; Male; Mice; Models, Statistical; Pyrroles; Reproducibility of Results; Solid Phase Extraction | 2013 |
Pharmacokinetics of sunitinib in combination with fluoroquinolones in rabbit model.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Aza Compounds; Biotransformation; Chromatography, High Pressure Liquid; Ciprofloxacin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Fluoroquinolones; Indoles; Injections, Intravenous; Levofloxacin; Male; Models, Animal; Moxifloxacin; Polypharmacy; Protein Kinase Inhibitors; Pyrroles; Quinolines; Rabbits; Spectrophotometry, Ultraviolet; Sunitinib | 2013 |
Discovery of 4-acetyl-3-(4-fluorophenyl)-1-(p-tolyl)-5-methylpyrrole as a dual inhibitor of human P-glycoprotein and Staphylococcus aureus Nor A efflux pump.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B; Bacterial Proteins; Binding Sites; Biological Transport; Caco-2 Cells; Ciprofloxacin; Coumarins; Dogs; Ethidium; Humans; Madin Darby Canine Kidney Cells; Mice, Inbred BALB C; Models, Molecular; Multidrug Resistance-Associated Proteins; Pyrroles; Rifampin; Staphylococcus aureus | 2015 |
Two approaches to the model drug immobilization into conjugated polymer matrix.
Topics: Ciprofloxacin; Delayed-Action Preparations; Drug Carriers; Microscopy, Electron, Scanning; Polymerization; Polymers; Pyrroles; Quercetin; Surface Properties | 2015 |
Identification of a Host-Targeted Compound to Control Typhoid Fever.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Humans; Pyrroles; Salmonella; Salmonella typhi; Typhoid Fever | 2022 |
Efficient photocatalytic degradation of ciprofloxacin by graphite felt-supported MnS/Polypyrrole composite: Dominant reactive species and reaction mechanisms.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Graphite; Humans; Polymers; Pyrroles | 2023 |